SynDISCO: A Mechanistic Modeling-Based Framework for Predictive Prioritization of Synergistic Drug Combinations

Sung-Young Shin1,2, Lan K Nguyen3,4

  • 1Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, VIC, Australia. Sungyoung.Shin@monash.edu.

Insights

Developing effective cancer combination therapies is crucial due to drug resistance. SynDISCO, a computational framework using ordinary differential equation (ODE) modeling, predicts synergistic drug combinations to overcome resistance and improve patient outcomes.

Area of Science:

  • Computational biology
  • Cancer research
  • Systems biology

Background:

  • Cancer monotherapies often face widespread drug resistance, limiting durable clinical benefit.
  • The vast number of potential drug combinations and cancer heterogeneity make experimental testing impractical.
  • Computational approaches are urgently needed to identify and prioritize effective combination treatments.

Purpose of the Study:

  • To present SynDISCO, a computational framework for predicting synergistic anti-cancer drug combinations.
  • To guide the application of SynDISCO for prioritizing combination therapies targeting signaling networks.
  • To demonstrate SynDISCO's utility using the EGFR-MET signaling network in triple-negative breast cancer.

Main Methods:

  • Leveraging mechanistic ordinary differential equation (ODE) modeling to simulate signaling networks.
  • Developing SynDISCO to predict synergistic drug combinations based on ODE models.
  • Applying SynDISCO to the EGFR-MET signaling network as a case study.

Main Results:

  • SynDISCO effectively predicts synergistic drug combinations by modeling underlying biological networks.
  • The framework demonstrated its application in identifying potential combination treatments for triple-negative breast cancer.
  • SynDISCO is a versatile, network- and cancer-independent computational tool.

Conclusions:

  • SynDISCO offers a practical computational approach to identify and prioritize synergistic drug combinations.
  • This framework can accelerate the discovery of novel combination therapies to overcome cancer drug resistance.
  • SynDISCO has broad applicability across different cancer types and signaling networks.

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
115
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
819
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
128
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.2K